Empirical studies have shown that hypermethylation of the tumor necrosis factor (TNF) promoter is correlated with mucosal inflammation in patients with IBD, indicating that methylation status may have a direct impact on disease severity and the viability of epithelial cells (Levic et al., 2024). Here, TNF is linked to inflammatory bowel disease.